104 related articles for article (PubMed ID: 3420535)
1. Enantiomer (+)physostigmine prevents organophosphate-induced subjunctional damage at the neuromuscular synapse by a mechanism not related to cholinesterase carbamylation.
Kawabuchi M; Boyne AF; Deshpande SS; Cintra WM; Brossi A; Albuquerque EX
Synapse; 1988; 2(2):139-47. PubMed ID: 3420535
[TBL] [Abstract][Full Text] [Related]
2. The reversible carbamate, (-)physostigmine, reduces the size of synaptic end plate lesions induced by sarin, an irreversible organophosphate.
Kawabuchi M; Boyne AF; Deshpande SS; Albuquerque EX
Toxicol Appl Pharmacol; 1989 Jan; 97(1):98-106. PubMed ID: 2916238
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of physostigmine as a pretreatment drug for protection of rats from organophosphate poisoning.
Deshpande SS; Viana GB; Kauffman FC; Rickett DL; Albuquerque EX
Fundam Appl Toxicol; 1986 Apr; 6(3):566-77. PubMed ID: 3699340
[TBL] [Abstract][Full Text] [Related]
4. Multiple actions of anticholinesterase agents on chemosensitive synapses: molecular basis for prophylaxis and treatment of organophosphate poisoning.
Albuquerque EX; Deshpande SS; Kawabuchi M; Aracava Y; Idriss M; Rickett DL; Boyne AF
Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S182-203. PubMed ID: 2868960
[TBL] [Abstract][Full Text] [Related]
5. Acetylcholinesterase inhibition by (+)physostigmine and efficacy against lethality induced by soman.
Harris LW; Anderson DR; Pastelak AM; Vanderpool B
Drug Chem Toxicol; 1990; 13(2-3):241-8. PubMed ID: 2276342
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the ultrastructural myopathy induced by anticholinesterase agents at the end plates of rat soleus and extensor muscles.
Meshul CK; Boyne AF; Deshpande SS; Albuquerque EX
Exp Neurol; 1985 Jul; 89(1):96-114. PubMed ID: 4007120
[TBL] [Abstract][Full Text] [Related]
7. Physostigmine--an overview as pretreatment drug for organophosphate intoxication.
Somani SM; Dube SN
Int J Clin Pharmacol Ther Toxicol; 1989 Aug; 27(8):367-87. PubMed ID: 2676871
[TBL] [Abstract][Full Text] [Related]
8. Interaction of reversible and irreversible cholinesterase inhibitors on the monosynaptic reflex in neonatal rats.
Das Gupta S; Bass KN; Warnick JE
Toxicol Appl Pharmacol; 1989 Jun; 99(1):28-36. PubMed ID: 2727998
[TBL] [Abstract][Full Text] [Related]
9. Physostigmine-induced hypothermic response in rats and its relationship with endogenous arginine vasopressin.
Yang YL; Shen ZL; Zou Q; Tang Y; Huang T
Life Sci; 2009 Oct; 85(15-16):586-91. PubMed ID: 19723529
[TBL] [Abstract][Full Text] [Related]
10. Effect of carboxylesterase inhibition on carbamate protection against soman toxicity.
Maxwell DM; Brecht KM; Lenz DE; O'Neill BL
J Pharmacol Exp Ther; 1988 Sep; 246(3):986-91. PubMed ID: 3418520
[TBL] [Abstract][Full Text] [Related]
11. Influence of pretreatment of carbamates on dynamic pulmonary mechanics in rats exposed to sarin aerosols.
Husain K; Kumar P; Vijayaraghavan R; Singh R; Das Gupta S
Indian J Physiol Pharmacol; 1993 Jul; 37(3):249-51. PubMed ID: 8276509
[TBL] [Abstract][Full Text] [Related]
12. Physostigmine modulation of acetylcholine currents in COS cells transfected with mouse muscle nicotinic receptor.
Svobodová L; Krůsek J; Hendrych T; Vyskocil F
Neurosci Lett; 2006 Jun; 401(1-2):20-4. PubMed ID: 16530961
[TBL] [Abstract][Full Text] [Related]
13. Protection from quinidine or physostigmine against in vitro inhibition by sarin of acetylcholinesterase activity.
Singh AK; Zeleznikar RJ; Drewes LR
Life Sci; 1986 Jan; 38(2):165-72. PubMed ID: 3945161
[TBL] [Abstract][Full Text] [Related]
14. Variability of neurotoxicity of and lack of tolerance to the anticholinesterases soman and sarin in the rat.
Fernando JC; Lim DK; Hoskins B; Ho IK
Res Commun Chem Pathol Pharmacol; 1985 Jun; 48(3):415-30. PubMed ID: 4023423
[TBL] [Abstract][Full Text] [Related]
15. Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds.
Eckert S; Eyer P; Mückter H; Worek F
Biochem Pharmacol; 2006 Jul; 72(3):344-57. PubMed ID: 16780806
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the efficacy of two carbamates, physostigmine and pyridostigmine, when used in conjunction for protection against organophosphate exposure.
Solana RP; Gennings C; Carter WH; Anderson D; Lennox WJ; Carchman RA; Harris LW
Fundam Appl Toxicol; 1990 Nov; 15(4):814-9. PubMed ID: 2086320
[TBL] [Abstract][Full Text] [Related]
17. Neuromuscular dysfunction induced by acetylcholinesterase inhibition.
Wecker L; Laskowski B; Dettbarn WD
Fed Proc; 1978 Dec; 37(14):2818-22. PubMed ID: 214351
[TBL] [Abstract][Full Text] [Related]
18. In vivo cholinesterase inhibitory specificity of organophosphorus nerve agents.
Shih TM; Kan RK; McDonough JH
Chem Biol Interact; 2005 Dec; 157-158():293-303. PubMed ID: 16256093
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of nine oximes on in vivo reactivation of blood, brain, and tissue cholinesterase activity inhibited by organophosphorus nerve agents at lethal dose.
Shih TM; Skovira JW; O'Donnell JC; McDonough JH
Toxicol Mech Methods; 2009 Sep; 19(6-7):386-400. PubMed ID: 19778239
[TBL] [Abstract][Full Text] [Related]
20. Transient and reversible nephrotoxicity of sarin in rats.
Bloch-Shilderman E; Levy A
J Appl Toxicol; 2007; 27(2):189-94. PubMed ID: 17154277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
